Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Medicine and Society Jul 2022 Co-creating an Art Exhibition on Living Well With Dementia Gloria Puurveen, PhD, Susan M. Cox, PhD, Natasha Damiano, MA, Heather Neale Furneaux, MFA, and Samantha Pineda Sierra, MFA This article considers ethical questions raised during development of an online art exhibit for and with people with dementia and their care partners. AMA J Ethics. 2022;24(7):E622-633. doi: 10.1001/amajethics.2022.622. Medicine and Society Jan 2008 Double Standard for Access to Pain Management Steven D. Passik, PhD and Kenneth L. Kirsh, PhD One of the many doors money and power often open gives access to opioids where they would otherwise be withheld without strict oversight and management. Elvis Presley provides perhaps the most famous example of unmanaged access to drugs. Virtual Mentor. 2008;10(1):49-54. doi: 10.1001/virtualmentor.2008.10.1.msoc1-0801. Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Medicine and Society Jul 2022 Co-creating an Art Exhibition on Living Well With Dementia Gloria Puurveen, PhD, Susan M. Cox, PhD, Natasha Damiano, MA, Heather Neale Furneaux, MFA, and Samantha Pineda Sierra, MFA This article considers ethical questions raised during development of an online art exhibit for and with people with dementia and their care partners. AMA J Ethics. 2022;24(7):E622-633. doi: 10.1001/amajethics.2022.622.
Medicine and Society Jan 2008 Double Standard for Access to Pain Management Steven D. Passik, PhD and Kenneth L. Kirsh, PhD One of the many doors money and power often open gives access to opioids where they would otherwise be withheld without strict oversight and management. Elvis Presley provides perhaps the most famous example of unmanaged access to drugs. Virtual Mentor. 2008;10(1):49-54. doi: 10.1001/virtualmentor.2008.10.1.msoc1-0801.
Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674.